CN Patent

CN112779304B — 一种并环吡啶酮化合物的制备方法

Assigned to Sunshine Lake Pharma Co Ltd · Expires 2023-11-03 · 3y expired

What this patent protects

本发明涉及一种并环吡啶酮化合物的制备方法，属于药物化学领域。本发明的方法采用酶催化反应，可以实现动态动力学拆分，将消旋体等转化为单一构型的化合物，避免异构体的浪费和减少异构体的回收，方法更为经济环保，有较高的生产应用价值。

USPTO Abstract

本发明涉及一种并环吡啶酮化合物的制备方法，属于药物化学领域。本发明的方法采用酶催化反应，可以实现动态动力学拆分，将消旋体等转化为单一构型的化合物，避免异构体的浪费和减少异构体的回收，方法更为经济环保，有较高的生产应用价值。

Drugs covered by this patent

Patent Metadata

Patent number
CN112779304B
Jurisdiction
CN
Classification
—
Expires
2023-11-03
Drug substance claim
No
Drug product claim
No
Assignee
Sunshine Lake Pharma Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.